Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drug Use-Results Survey of Opdivo in Unresectable Advanced or Recurrent Gastric Cancer After Chemotherapy
jRCT1080224011Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Jul 2018
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of nivolumab in gastric cancer (GC), sponsored by Ono Pharmaceutical. Started Jul 2018; status: completed.
02
Drugs
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on jRCT1080224011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080224011.